homeWelcome, sign in or click here to subscribe.login
     


 

 

Business


Subscriber content preview

March 24, 2020

Malaria drugs' promise for virus spurs hope, shortages

  • Scientists say major studies are needed to prove the drugs are safe and effective against coronavirus.
  • By MARILYNN MARCHIONE
    AP Chief Medical Writer

    Excitement about treating the new coronavirus with malaria drugs is raising hopes, including with President Donald Trump. But the evidence that they may help is thin, and a run on the drugs is complicating access for people who need them for rheumatoid arthritis or lupus.

    Chloroquine and a similar drug, hydroxychloroquine, showed encouraging signs in small, early tests against the coronavirus. But the drugs have major side effects, one reason scientists don't want to give them without evidence of their value, even in this emergency.


     
    . . .


    To read this story in full login or purchase a subscription.



    
    Email or user name:
    Password:
     
    Forgot password? Click here.